Wayne Embree

Executive Vice President, Investments & Venture Acceleration

Wayne is an experienced seed-stage investor with a track record of fueling startups with guidance and venture capital. He’s been involved in over 200 investments, including sitting on over 50 boards and taking more than 60 businesses through exits. Throughout his career, he has maintained his passion and enthusiasm for helping entrepreneurs change the world. Wayne has a BS in Natural Sciences from Western Oregon and an MS in Urban Planning from the University of Oregon.

Posts by Wayne Embree

Nationwide Children’s Spinouts Focus on Promising Gene Therapy

The first successful gene therapy—modifying a person’s DNA to treat disease—occurred in 1990. In the nearly three decades since those pioneering treatments, there are thousands of gene therapy studies and… Read more

Posted 12/18/2018 by Wayne Embree in #Startup Buzz

Six Reasons Veterans Make Excellent Entrepreneurs

This week we give special recognition and honor to our military veterans on Veteran’s Day. It’s an opportunity to say thank you for your service to the veterans who are… Read more

Posted 11/12/2018 by Wayne Embree in #Startup Buzz

Celenex: Determined Parents Champion Treatment to Save Children’s Lives

The story of Celenex is special. It starts with two passionate, devoted parents whose daughters were born with Batten disease (also known as Neuronal ceroid lipofuscinosis – NCL), one of… Read more

Posted 11/8/2018 by Wayne Embree in #Startup Buzz

How to Connect with Investors and Choose the Right One

As the founder of several successful healthcare and technology companies, and an investor himself, Ray Shealy, CEO understands that great working relationships between investors and entrepreneurs are critical to a... Read more

Posted 10/16/2018 by Wayne Embree in Getting Funding

Sollis Therapeutics Develops Non-opioid Therapy for Sciatica

If you are one of the five million or more people in the United States who is afflicted by sciatica (lumbosacral radiculopathy), you know how sharply painful sciatica can be.... Read more

Posted 10/11/2018 by Wayne Embree in #Startup Buzz

How Deep Lens Helps Pathologists and Patients Battle Disease

In medicine, pathologists are known as the doctors’ doctors. Whether the task at hand is to diagnose an individual patient or to study the influence of a particular cell on… Read more

Posted 7/26/2018 by Wayne Embree in #Startup Buzz

Myonexus Therapeutics Secures $2.5 Million Seed Financing to Clinically Advance Limb-Girdle Muscular Dystrophy (LGMD) Gene Therapies

MYO-101 Phase 1/2a systemic gene therapy trial for LGMD2E to begin in early 2018 New Albany, OH, 13 December 2017 – Myonexus Therapeutics, Inc. (Myonexus), a clinical-stage biotechnology company developing… Read more

Posted 12/13/2017 by Wayne Embree in #Startup Buzz

Myonexus Poised to Unlock Gene Therapy for Limb-Girdle Muscular Dystrophy

Myonexus Therapeutics is a clinical stage gene therapy company developing first-ever gene treatments for multiple types of limb-girdle muscular dystrophy (LGMD), a group of progressive, debilitating musculoskeletal genetic diseases that… Read more

Posted 12/13/2017 by Wayne Embree in #Startup Buzz

Noxsano’s Innovative Approach to Preventing Amputation

The Columbus-based startup, Noxsano is a reminder that not all medical technology comes from state-of-the-art laboratories in large research institutions. Like Microsoft and Hewlett Packard, the technology at the core… Read more

Posted 11/2/2017 by Wayne Embree in #Startup Buzz